• Frustratingly in the past years the world

  2019-05-30

  

  Frustratingly, in the past 40 years the world has added only two new drugs to the arsenal against tuberculosis, the second most deadly infectious disease on the planet. The statistics are infuriating: more than 9 million people developed tuberculosis in 2013, and an estimated 44% of those in countri

• br Introduction Incidence of oral cancers accounts

  2019-05-30

  

  Introduction Incidence of oral cancers accounts for ∼3% of all malignancies. Oral squamous cell carcinoma (OSCC) accounts for >95% of all malignancies in the oral cavity, and it is the fifth leading cause of cancer death in the male population in Taiwan. OSCC is treated mainly with surgery. Pos

• br Discussion Rarely a breast cancer patient has histologica

  2019-05-30

  

  Discussion Rarely, a breast cancer patient has histologically proven breast cancer found outside the breast without a detectable primary breast tumor. Almost always the site of detected disease is an axillary lymph node. The incidence of axillary breast cancer with occult primary is relative low

• Most spinal schwannomas derived from Schwann cells

  2019-05-30

  

  Most spinal schwannomas derived from Schwann telomerase inhibitor along the dorsal sensory roots involve radicular pain as the most common initial symptom. However, symptoms may be subtle and progress slowly over time, owing to the slow-growing nature of these tumors. In our case, it\'s more diffic

• br Conflict of interest br Introduction Landiolol is an

  2019-05-30

  

  Conflict of interest Introduction Landiolol is an intravenous short-acting beta-adrenoreceptor blocker, and its wide use is exhibited by rapid wash out and a less-sustained effect on cardiac function after decreasing the dose or stopping its administration [1]. We present a patient with drug-r

• BB-94 Limitations of meta analyses are often based on the st

  2019-05-30

  

  Limitations of meta-analyses are often based on the strength of the data available. Only 26% of the eligible studies were judged to be at low risk of overall bias in this analysis. Other studies may have been at low risk for bias but failed to report information necessary for this determination. All

• The comparative consensus modelling approach used by

  2019-05-30

  

  The comparative consensus modelling approach used by Eaton and colleagues is now used frequently to justify the implementation of particular HIV interventions. However, this approach produces meaningful results only if the comparison is based on valid models. Most comparative consensus studies (incl

• The Sustainable Development Goals can be achieved

  2019-05-29

  

  The Sustainable Development Goals can be achieved through environmental prevention of diseases without an additional burden on resources. The WHO avoidable early environmental exposures initiative emphasises that the unrecognised health risks are most damaging to the human population. An absence of

• Rabies has no cure and by

  2019-05-29

  

  Rabies has no cure, and by the time of clinical onset it is invariably fatal. More than 95% of deaths occur in Africa and Asia, 80% of which are in people living in rural, underserved populations, most of whom are children. Community awareness about the power of preventing dog bites and of life-savi

• hsp70 inhibitor Many of the emerging non vaccine serotypes i

  2019-05-29

  

  Many of the emerging non-vaccine serotypes in carriage after PCV13 implementation (11A, 15B/C, 15A, 21, 23B, and 35F) show low potential for causing invasive disease, but some—eg, 12F, 22F, 24F, 8, and 9N—have high disease potential. Moreover, in vulnerable populations (eg, immunocompromised people)

• The overall MSTS score in our study was The MSTS

  2019-05-29

  

  The overall MSTS score in our study was 97.3%. The MSTS score after curettage treatment was 99%, better than that in previous studies, which ranged from 90% to 93%. Two cohort studies showed higher MSTS scores for patients who underwent intralesional curettage than those who underwent wide resection

• protease activated receptor Furthermore many potential risk

  2019-05-29

  

  Furthermore, many potential risk factors were examined in the current study, which contained a broad array of factors. Based on such a classification, groups of some factors were earlier referenced in the literature. Although the distribution of association between some risk factors and SRH were sim

• In our study acute toxicities were mild and

  2019-05-29

  

  In our study, acute toxicities were mild, and there were no Grade 3 or above hematologic toxicities. Only one patient (3.2%) had Grade 3 esophagus toxicity and three patients (9.7%) had Grade 3 lung toxicity. Compared with studies that investigated regimens of oxaliplatin and 5-FU/leucovorin, the pr

• We moreover confirmed previous evidence

  2019-05-29

  

  We, moreover, confirmed previous evidence of a net increase of CT density of bone metastases after ZA treatment and demonstrated that the changes persist at a 24 months follow-up. This study and previous reports [24–26] have demonstrated significant sclerotic changes of BMs, more evident in patients

• As with any open label study it

  2019-05-29

  

  As with any open-label study, it is possible that a placebo effect may have contributed to patients analgesia after initiation of the therapy. A randomized placebo-controlled trial would be required to finally prove the high analgesic effect of the loading-dose treatment with Ibandronate in metastat

14664 records 958/978 page Previous Next First page 上5页 956957958959960 下5页 Last page